Sunday 29 March 2020

Gilead Declines 'Rare Disease' Status For Experimental Coronavirus Drug - In a surprising turnabout, drugmaker Gilead Sciences asked the Food & Drug admin to rescind orphan status for remdesivir, the company's experimental coronavirus treatment.

Gilead Declines 'Rare Disease' Status For Experimental Coronavirus Drug - In a surprising turnabout, drugmaker Gilead Sciences asked the Food & Drug admin to rescind orphan status for remdesivir, the company's experimental coronavirus treatment. submitted by /u/anutensil
[link] [comments]


from Health https://ift.tt/3dDzwQ3
via IFTTT

No comments:

Post a Comment